Stocks
Organogenesis Holdings Inc.ORGO
NASDAQHealthcareBiotechnology$0.99
Price as of · delayed, not real-time
A commercial-stage regenerative medicine company focused on advanced wound care and surgical biologics, offering products like skin substitutes and tissue repair matrices. Investors track ORGO for its position in the wound care market and its revenue growth trajectory.
52W Range: $0.93-$7.08
Congressional Interest in Organogenesis Holdings Inc. (ORGO)
No congressional trades have been disclosed for Organogenesis Holdings Inc. (ORGO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ORGO?
No congressional trades found for this stock.